Activation/NN
of/IN
Ras/NN
and/CC
mitogen-activated/JJ
protein/NN
kinase/NN
pathway/NN
by/IN
terminal/JJ
complement/NN
complexes/NNS
is/VBZ
G/NN
protein/NN
dependent/JJ
./.

Assembly/NN
of/IN
terminal/JJ
complement/NN
complexes/NNS
(/(
TCC/NN
)/)
C5b-7/NN
,/,
C5b-8/NN
,/,
and/CC
C5b-9/NN
on/IN
target/NN
cells/NNS
during/IN
acute/JJ
and/CC
chronic/JJ
inflammation/NN
induces/VBZ
hydrolysis/NN
of/IN
plasma/NN
membrane/NN
phospholipids/NNS
and/CC
heterotrimeric/JJ
G/NN
protein/NN
activation/NN
./.
=====
TCC/NN
also/RB
stimulate/VBP
a/DT
variety/NN
of/IN
cellular/JJ
activities/NNS
,/,
which/WDT
include/VBP
cytokine/NN
synthesis/NN
,/,
proto-oncogene/JJ
activation/NN
,/,
and/CC
mitotic/JJ
signaling/NN
./.
=====
Now/RB
we/PRP
report/VBP
that/IN
sublytic/JJ
TCC/NN
induced/VBD
Ras/NN
,/,
Raf-1/NN
,/,
and/CC
extracellular/JJ
signal-regulated/JJ
kinase/NN
(/(
ERK/NN
)/)
1/CD
activation/NN
in/IN
JY25/NN
B/NN
cell/NN
line/NN
./.
=====
When/WRB
cells/NNS
were/VBD
exposed/VBN
to/TO
C5b-9/NN
,/,
GTP-bound/JJ
Ras/NN
in/IN
anti-C5b-9/JJ
immunoprecipitates/NNS
was/VBD
increased/VBN
3.2-fold/RB
at/IN
2/CD
min/NN
,/,
while/IN
GTP-bound/JJ
Ras/NN
in/IN
anti-Ras/JJ
immunoprecipitates/NNS
was/VBD
increased/VBN
2-fold/RB
at/IN
10/CD
min/NN
./.
=====
Both/CC
C5b-9/NN
and/CC
C5b-7/NN
,/,
but/CC
not/RB
C5b6/NN
,/,
increased/VBD
Raf-1/NN
kinase/NN
activity/NN
maximum/NN
3.3-fold/RB
at/IN
2/CD
min/NN
and/CC
2.8-fold/RB
at/IN
5/CD
min/NN
,/,
respectively/RB
./.
=====
ERK1/NN
activity/NN
was/VBD
2-fold/RB
increased/VBN
by/IN
C5b-9/NN
at/IN
2/CD
min/NN
and/CC
by/IN
C5b-7/NN
at/IN
10/CD
min/NN
,/,
over/IN
the/DT
C5b6/NN
level/NN
./.
=====
The/DT
role/NN
of/IN
mitogen-activated/JJ
protein/NN
kinase/NN
(/(
MAPK/NN
)/)
pathway/NN
on/IN
TCC-inducible/JJ
mitotic/JJ
signaling/NN
was/VBD
evaluated/VBN
by/IN
assessing/VBG
DNA/NN
synthesis/NN
and/CC
activator/NN
protein/NN
1/CD
(/(
AP-1/NN
)/)
DNA-binding/NN
activity/NN
./.
=====
The/DT
MAPK/ERK-specific/JJ
inhibitor/NN
PD/NN
098,059/CD
abolished/VBD
the/DT
C5b-9-induced/JJ
DNA/NN
synthesis/NN
./.
=====
Involvement/NN
of/IN
G/NN
protein/NN
in/IN
the/DT
activation/NN
of/IN
MAPK/NN
pathway/NN
by/IN
TCC/NN
was/VBD
indicated/VBN
by/IN
inhibition/NN
of/IN
Raf-1/NN
and/CC
ERK1/NN
kinase/NN
activity/NN
,/,
as/RB
well/RB
as/IN
the/DT
DNA/NN
synthesis/NN
by/IN
pretreatment/NN
of/IN
cells/NNS
with/IN
pertussis/NN
toxin/NN
./.
=====
Overexpression/NN
of/IN
beta-adrenergic/JJ
receptor/NN
kinase/NN
1/CD
carboxyl-terminal/JJ
peptide/NN
in/IN
JY25/NN
cells/NNS
also/RB
inhibited/VBD
Raf-1/NN
and/CC
ERK1/NN
activity/NN
,/,
indicating/VBG
a/DT
direct/JJ
involvement/NN
of/IN
G/NN
betagamma/NN
subunits/NNS
in/IN
the/DT
signal/NN
transduction/NN
generated/VBN
through/IN
activation/NN
of/IN
MAPK/NN
pathway/NN
by/IN
TCC/NN
assembly/NN
in/IN
the/DT
plasma/NN
membrane/NN
./.